Cline Christopher R. sold TVTX
August 27, 2025 · Form 4 insider transaction
Cline Christopher R. sold 470 shares of Travere Therapeutics, Inc. at $17.31 per share, a transaction worth $8.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
470
Price
$17.31
Total value
$8.1K
InsiderCline Christopher R.
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 27, 2025
Filing dateAugust 28, 2025
Shares owned after92,656
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This sale was made pursuant to a written plan adopted on May 28, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of additional shares to cover the tax obligation that occurred upon the vesting of performance-based restricted stock units (PSUs) that vested in May 2025.